Faculty of Health Sciences, Universidad Alfonso X el Sabio, Madrid, Spain.
Rafa Nadal Academy, Manacor, Mallorca, Spain.
PLoS One. 2024 Nov 7;19(11):e0309232. doi: 10.1371/journal.pone.0309232. eCollection 2024.
Tennis is a globally popular sport known for its numerous health benefits. However, it also underscores the physical demands and potential injuries associated with high-performance play. This review emphasizes the role of kinetic chains in executing powerful movements and discusses common injuries, particularly in the upper limbs due to the sport's overhead nature. It highlights the importance of effective rehabilitation methods for swift recovery and long-term performance enhancement in high-performance tennis players.
The review aims to investigate the relationship between age, sex, and injury prevalence among high-performance tennis players to inform injury prevention strategies.
This review protocol will provide a description on effective rehabilitation methods to tennis players, aiding coaches, physiotherapists and physicians. Methodologically, this systematic review will develop following the PRISMA guidelines, focusing on articles published between 2011 and 2024, with eligibility criteria specified. Data collection involved screening titles and abstracts, removing duplicates, and assessing full texts for eligibility. Data extraction will include information on authors, publication year, evidence level, participant demographics, injuries, treatments, etc. The GRADE framework will be used for evidence quality assessment, and NIH criteria were applied for study quality assessment.
Prospero registration number: CRD42023453182.
网球是一项全球性的流行运动，以其众多的健康益处而闻名。然而，它也强调了与高性能比赛相关的身体需求和潜在伤害。本综述强调了运动链在执行有力动作中的作用，并讨论了常见的损伤，特别是由于运动的头顶性质而在上肢的损伤。它强调了有效康复方法在高性能网球运动员中快速恢复和长期性能提升的重要性。
本综述旨在研究年龄、性别与高性能网球运动员损伤发生率之间的关系，为损伤预防策略提供信息。
本综述方案将提供针对网球运动员的有效康复方法描述，以帮助教练、物理治疗师和医生。本系统综述将按照 PRISMA 指南进行方法学制定，重点关注 2011 年至 2024 年期间发表的文章，并规定了入选标准。数据收集包括筛选标题和摘要、去除重复项，以及评估全文的入选资格。数据提取将包括作者、出版年份、证据水平、参与者人口统计学、损伤、治疗等信息。将使用 GRADE 框架评估证据质量，并应用 NIH 标准评估研究质量。
PROSPERO 注册号：CRD42023453182。
